Korsana Biosciences Earnings
NASDAQ: KRSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
33.92+0.41 (+1.22%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Korsana Biosciences earnings summary
In its most recent report on Aug 4, 2026 (Q2 2026), KRSA posted EPS of $-0.41. Revenue for the quarter was $0. Across the last 16 reports, KRSA shares moved an average of 13.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
KRSA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-0.41 | — | +6.2% |
| May 12, 2026 | — | $-0.76 | — | +1.9% |
| Mar 30, 2026 | — | $-0.14 | — | -52.7% |
| Nov 12, 2025 | — | $-0.30 | — | +8.8% |
| Aug 5, 2025 | — | $-0.11 | — | +2.8% |
| May 6, 2025 | — | $-0.56 | — | -7.3% |
| Mar 4, 2025 | — | $0.23 | — | -9.6% |
| Nov 14, 2024 | — | $-0.29 | — | -44.6% |
| Aug 7, 2024 | — | $-0.53 | — | -10.7% |
| May 7, 2024 | — | $-0.62 | — | -9.5% |
| Mar 5, 2024 | — | $0.06 | — | +3.8% |
| Nov 13, 2023 | — | $2.72 | — | -3.4% |
| Jul 28, 2023 | — | $-1.83 | — | +18.9% |
| May 12, 2023 | — | $-3.20 | — | +17.9% |
| Mar 22, 2023 | — | $-8.99 | — | -0.7% |
| Nov 3, 2022 | — | $-4.83 | — | +18.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.